ARDS was underrecognized in the study population across all body mass indexesBMIs, but this underrecognition did not explain why patients with class 3 obesity were more likely to meet ARDS criteria but not receive low tidal volume ventilation.
Metformin was effective in reducing pulmonary fibrosis in human IPF fibroblasts and when used in combination with low-dose nintedanib, demonstrated a synergistic, antifibrotic effect.
Statin therapy before septic shock may decrease the risk for acute respiratory distress syndrome.
Researchers of the study aimed to determine the differences in muscle area and bone density in patients with end-stage lung disease.
Plasma biomarkers of progressive idiopathic pulmonary fibrosis may be markers of progressive pulmonary fibrosis regardless of the type of interstitial lung disease.
Prehospital vulnerability was associated with higher 1-year mortality but not with acute respiratory distress syndrome or short-term mortality.
The FDA has approved Ofev capsules as the first FDA-approved treatment to slow the rate of decline in pulmonary function in patients with systemic sclerosis-associated ILD.
An increased right to left ventricle diameter ratio may help identify high-risk patients with suspected interstitial lung disease/pulmonary hypertension.